High level expression of the multidrug resistance (MDR1) gene in the normal bladder urothelium: A potential involvement in protection against carcinogens?

Carcinogenesis

Volumn 17, Issue 3, 1996, Pages 601-604

  Clifford, Steven C ^a   Neal, David E ^a   Lunec, John ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN P; MESSENGER RNA;

ARTICLE; BLADDER; BLADDER CARCINOGENESIS; BLADDER CARCINOMA; CANCER GROWTH; CANCER RISK; GENE EXPRESSION; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; UROTHELIUM;

DRUG RESISTANCE, MULTIPLE; ENDOTHELIUM; HUMANS; P-GLYCOPROTEIN; RNA, MESSENGER; URINARY BLADDER;

EID: 0029983195     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/17.3.601     Document Type: Article

References (37)

1. Davies,J.M. (1982) Occupational and environmental factors in bladder cancer. In Chisholm,G.D. and Innes-Williams,D. (eds), Scientific Foundations of Urology, 2nd edn. Heineman, London, pp. 723-727.
2. Mostofi,F.K., Davis,C.J. and Sesterhenn.I.A. (1988) Pathology of tumours of the urinary tract. In Skinner,D.G. and Lieskovsky,G. (eds), Diagnosis and Management of Genitourinary Cancer. W.B.Saunders Company. London, pp. 83-117.
3. Russell,P.J., Raghavan,D., Philips,J. and Wills,E J. (1988) The biology of urothehal cancer. In Raghavan,D. (ed.), The Management of Bladder Cancer. Edward Arnold, London, pp. 1-41.
4. Parkin,D.M., Muir,C.S., Whelan,S.L., Gao,Y.T., Ferlay,J. and Powell,J. (eds) (1992) Cancer incidence in five continents. IAKC Scientific Publication No. 120. International Agency for Research on Cancer, Lyon, France.
5. Ross,R.K., Paganini-Hill, and Henderson,B.E. (1988) Epidemiology of bladder cancer. In Skinner,D.G. and Lieskovsky,G. (eds), Diagnosis and Management of Genitourinary Cancer. W.B Saunders Company, London, pp. 23-31.
6. Archer,M.C. (1992) Chemical carcinogenesis. In Tannock,I.F. and Hill,R.P. (eds), The Basic Science of Oncology. McGraw-Hill, Inc., London, pp. 102-118.
7. Conney,A.H, Garland,W.A., Rubio,F., Kornychuck,H., Norkus,E.P. and Kuenzig,W. (1986) Factors influencing the urinary excretion of nitrosodimethylamine and nitrosoproline in human beings. In Hoffmann,D. and Harris,C.C. (eds), Mechanisms in Tobacco Carcinogenesis. Cold Spring Harbor, New York, pp 21-32.
8. El-Bayoumy,K., Donahue,J., Hecht,S.S. and Hoffman,D. (1986) Analysis of o-toluidine in human urine. In Hoffmann,D. and Harris,C.C. (eds), Mechanisms in Tobacco Carcinogenesis. Cold Spring Harbor, New York, pp. 77-84.
9. Raghavan,D. (1988) The management of bladder cancer: current practice and future prospects. In Raghavan,D. (ed ), The Management of Bladder Cancer E.J Arnold, London, pp. 317-332.
10. Hendry,W.F, (1988) Diagnosis and management of bladder cancer a British perspective In Raghavan,D. (ed.), The Management of Bladder Cancer. E.J.Arnold, London, pp. 67-93.
11. Chen,C.J., Chin,J.E., Ueda,K., Clark,D.P., Pastan,I., Gottesman,M.M and Roninson,I.B. (1986) Internal duplication and homology with bacterial transport proteins in the MDR1 (P-glycoprotein) gene from multidrug-resistant human cells. Cell, 47, 381-389.
12. Ueda,K., Cornwell,M.M., Gottesman,M.M., Pastan,I., Roninson,I.B., Ling,V. and Riordan,J.R. (1986) The MDR1 gene, responsible for multidrug resistance, codes for P-glycoprotein. Biochem. Biophys. Res. Commun., 141, 956-962.
13. Juliano,R.L. and Ling,V. (1976) A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim. Biophys. Acta, 455, 152-162.
14. Endicott,J.A. and Ling,V. (1989). The biochemistry of P-glycoprotein mediated resistance. Annu. Rev. Biochem., 58, 136-171.
15. Ueda,K., Cardarelli,C., Gottesman,M.M. and Pastan,I. (1987) Expression of a full length cDNA for the human MDR1 gene confers cross-resistance to colchicine, doxorubicin and vinblastine. Proc. Natl Acad. Sci. USA, 84, 3004-3020.
16. Gottesman,M.M. (1993) How cancer cells evade chemotherapy: sixteenth Richard and Hinda Rosenthal foundation award lecture. Cancer Res., 53, 747-754.
17. Fojo, J.A., Ueda,K , Salmon,D.J., Poplack,D.G. Gottesman,M.M. and Pastan,I. (1987) Expression of a multidrug resistance gene in human tumors and tissues. Proc. Natl Acad. Sci. USA, 84, 265-269.
18. Thiebaut,F., Tsuruo,T., Hamada,H., Gottesman,M.M. and Pastan,I. (1987) Cellular localisation of the multidrug resistance gene product P-glycoprotein in normal human tissues. Proc. Natl Acad. Sci. USA, 84, 7735-7738.
19. Cordon-Cardo,C. (1991) Immunohistochemical analysis of P-glycoprotein expression in normal and tumor tissues in humans. In Roninson,I. (ed.), Molecular and Cellular Biology of Multidrug-Resisiance in Tumor Cells. Plenum Press. New York, pp. 303-318.
20. Gottesman,M.M., Wilingham,M.C., Thiebaut,F. and Pastan,I. (1991b) Expression of the MDR1 gene in normal human tissues. In Roninson,I. (ed.), Molecular and Cellular Biology of Multidrug-Resistance in Tumor Cells. Plenum Press, New York, pp. 279-290.
21. Clifford,S.C.,Thomas,D.J., Neal,D.E. and Lunec,J. (1994) Increased MDR1 gene transcript levels in high-grade carcinoma of the bladder determined by quantitative PCR-based assay. Br. J. Cancer, 69, 680-686.
22. Goldstein,L.J., Galski,H., Fojo,A. et al. (1989) Expression of a human multidrug resistance gene in human cancers. J. Natl Cancer Inst., 81, 116-124
23. Lunec,J. and Mellon,K. (1994) Molecular biology and bladder cancer. In Neal,D.E. (ed.), Tumours in Urology. Springer-Verlag, pp. 19-45.
24. Devlin,J., Keen,A.J. and Knowles,M A. (1994) Homozygous deletion mapping at 9p21 in bladder carcinoma defines a critical region within 2cM of IFNA Oncogens, 9, 2757-2760.
25. Knowles,M.A. (1995) Molecular genetics of bladder cancer. Br. J. Cancer, 75 (Suppl. 1), 57-66.
26. Chin,K.V., Ueda,K., Pastan,I. and Gottesman,M.M. (1992) Modulation of activity of the promoter of the human MDR1 gene by ras and P53 Science, 255, 459-462.
27. Yeh,G.C., Lopaczynska,J., Poore,C.M and Phang,J.M. (1992) A new functional role for P-glycoprotein: efflux pump for benzo[a]pyrene in human breast cancer MCF-7 cells. Cancer Res , 52, 6692-6695.
28. Phang,J.M., Poore.C.M., Lopoczynska,J. and Yeh,G.C. (1993) Flavanol-stimulated efflux of 7.12-dimethylbenz[a]anthracene in multidrug-resistant breast cancer cells. Cancer Res., 53, 5977-5981.
29. Bell,D.A, Taylor,J A., Paulson,D.F., Robertson,C.N., Mohler,J.L. and Lucier,G.W. (1993) Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer. J Natl Cancer Inst., 85, 1159-1164.
30. Brockmoller,J., Kerb,R., Drakoulis,N., Staffeldt,B. and Roots,I (1994) Glutathione S-transferase M1 and its variants A and B as host factors of bladder cancer susceptibility a case-control study. Cancer Res., 54, 4103-4111.
31. Hirvonen,A., Nylund,L., Kociba,P., Huscgavel-Pursiaien,K. and Vainio,H (1994) Modulation of urinary mutagenicity by genetically determined carcinogen metabolism in smokers. Carcinogenesis, 15, 813-815.
32. Mommsen,S., Sell,A. and Barfod,N. (1982) Letter: N-aceryl transferase phenotypes of bladder cancer patients in a low risk population. Lancet, ii, 1228.
33. WoIf,H., Loer,G.M. and Bryan.G.T. (1980) Role of N-acetyl-transferase phenotype in human susceptibility to bladder carcinogenic arylammes. Scad. J.Urol. Nephrol. 14, 161-165.
34. Daly,A.K., Thomas,D.J., Neal,D.E. and Idle,J.R. (1993) Homozygous deletion of gene for glutathione S-transferase MI in bladder cancer. Br. Med. J., 307, 481-482.
35. Raderer,M. and Scheithauer,W. (1993) Clinical trials of agents that reverse multidrug resistance. Cancer, 72, 3553-3563.
36. Lum,B.L., Fisher,G.A., Brophy,N.A., Yahanda,A.M., Adler,K.M., Kaubisch,S., Halsey,J. and Sikic,B.I. (1993) Clinical trials of modulation of multidrug resistance. Cancer, 72, 3502-3514
37. Noonan,K.E., Beck,C., Holzmayer,T.A et al. (1990) Quantitative analysis of MDR1 gene expression in human tumors by polymerase chain reaction. Proc. Natl Acad. Sci. USA, 87, 7160-7164.